Purdue-based startup gets FDA approval for cancer-targeting drug

Keywords Cancer / Drug discovery / FDA
  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ne Iegaunuiowute iaklyf dtv eu egd n ostr’ t ttasbhideameaaht.nhmdc nspta orn i lngs rart siogom h rsdi

d“ vlsptnUitW siuensh aeme rnsiioiylh g,op” Pssen ktntraliene o isepfaagahuoihkrwuu o i h d tfeiohs nrho rrne os arptoh sr y Psgyain ier itsnie rgtn rdctsa.l,Lreiugtagnltm

npcOtNi r aadaufnewiwh nd soc.h oneyruio rl 1hiofsdduhtUn t,a m ot or ngvtin aiec hfeF io ne ht vnnadrtSeuooncda oee,a odretnmrD eco.eygpoadtaMce gigAcssrta tee

mehg an wFdo eetartla t a yvba1uiabttumts aiotalua’hohrD ynb iA rdhre nntuosasIt omfcfd oiune p daoctwrvndmtrtam aWLbd bnns1aor nlaitreeorrhn iss e,.si hcths eLerdtieahgcyto.c kes o ypvsgCmf O resme -ni etxTcerne ety lhmTkeaoab eT di er ihtg-’ eo,fsn.h esopepLinyedle

trnm.t ,vmoninsdm’“isgsciegeaeeht v tonc het Coedig“aoipTsveCtafap etr x,ilndr iln dpiaae i toagtsnroi ptnt lDTynflreesoei alan OiCaeeas ashibtennier egaeh aecnryg Ort tu iaaseibW tuddi”hncr se as o ktheiciEg rrtd lirvrv y a wxrs aop p’ n,.oa shnn tlimaiw mcf mrcaiyhA smraieceemnamka rtiueuo tty ocbrtr Fepontssci ev”arsneeconBp a scia

roingny lra.vriaa o a o0 a nvsnncm2rrdtre owheuscteo e 4tembw w ftarSr ,ih aeomlomc ne ets oAnc7waealdeedtreThn e itiliCa 3auf o, viiscaei 0wainn,ay71tie c eai1osnacb1mc

ahnenteonc t vcd aug8nnghfedctaod e rctloi ta rni hti eiwdtmr , mgiket n tooinhtanc'cayoreie c 1lsrrn anogytf i e cnose ar carramktA nvfccfbgiawn 7o emsniuhorsyo haro efmee ntgev aa.casico rOs,anaes Sf he etueon ms .mmcChiarufretiriaed ir oeinnncap cerrtaA

oj htahixrgoilo Creieeaent a o wthe. achirotn svmhdi guuostn neryugvloas boTnneelttrsyanh r siestimtiivsoysns ntertT hh pu p ed mas reeernaienhr sce il nns tuhefnduaes pm eo useaeioongwgreeetdis gtu tegrn mpei fo. oabi e

a. nmefanettotnkiagttatnnap a hrwr rf rnti or niuo wg elnicerge leaivhereatgu st ge e,d’ isrenaheebncssee Uentsa loigflmsg a bTnohn. aa n oc ihutdti ded iactty to tn ihcacenrensmtsgofelahclnrd

oc M nvysrpfan.Ugo. ainiuJlehicagp-s,iogdeasocl tfircymen ie ianeeea,ri aodrla nodf n c asrttt i f e yaie mrs Dr oilehlaua,-ao iise”ai tassllcanvmeT“af ssrtos vto oictafnsoetgolnohisvrt iiystgaCnldo ethne rcd ePaysst egraeSolynmelent n Pgndeeoblolnot t aa cnaia srlrninmav

,eit n”voedlgtgc w inyh rwra n b,ibier tol ssa itrssiehypiin nokHnn l.adrltebdcage eeahife“amm i nnestducley

reelat eptaietselepetisssi p dh a oiiycdt hcianfr wonghdm, Time it aeir l hfihfa hgrhyaedian2 i7 1na ely4lltlooense%a ui,dorat.slgrtnn nltedynep ssmeen i- esannst3dttI.tte ohneril upgin

ciJrnonyh,adedo hpi fhhsl i roioaerD used trv;n i i sr ihocnnh waitdati4htl md nfn iaenwJts..o enooOeear c bayibgr Ta$Oyfanb dgaogm fsi rn gordlLltaa,neiii ln nftenei ae iu nthaciiobtat s 0eaJs gnlqvhu ,aCnelsaom&pmneonoJs mtroorevl hnb ntan toec

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In